2.16
Collplant Biotechnologies Ltd stock is traded at $2.16, with a volume of 26,838.
It is down -1.37% in the last 24 hours and down -19.70% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.19
Open:
$2.25
24h Volume:
26,838
Relative Volume:
0.27
Market Cap:
$27.47M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-1.7705
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-5.26%
1M Performance:
-19.70%
6M Performance:
+1.89%
1Y Performance:
-41.34%
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CLGN
Collplant Biotechnologies Ltd
|
2.16 | 27.85M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
Will CollPlant Biotechnologies Ltd. stock go up soonEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Will CollPlant Biotechnologies Ltd. stock deliver better than expected guidanceJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Will CollPlant Biotechnologies Ltd. stock outperform Nasdaq indexLayoff News & Free Community Supported Trade Ideas - newser.com
What Wall Street predicts for CollPlant Biotechnologies Ltd. stock priceMarket Performance Summary & Long-Term Capital Growth Strategies - newser.com
Is CollPlant Biotechnologies Ltd. stock trading at a premium valuationJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com
How CollPlant Biotechnologies Ltd. stock benefits from tech adoptionJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Will CollPlant Biotechnologies Ltd. (CPT) stock benefit from commodity supercycleWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How CollPlant Biotechnologies Ltd. (CPT) stock performs in easing cyclesAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com
How CollPlant Biotechnologies Ltd. stock reacts to oil pricesGap Down & Verified Momentum Stock Watchlist - newser.com
When is the best time to exit CollPlant Biotechnologies Ltd.Analyst Upgrade & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-01 12:25:08 - newser.com
How CollPlant Biotechnologies Ltd. stock trades during market volatilityQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
What is the fair value of CollPlant Biotechnologies Ltd. stock now2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Is CollPlant Biotechnologies Ltd. forming a bottoming baseQuarterly Trade Review & Safe Entry Point Identification - newser.com
Collplant Biotechnologies Ltd expected to post earnings of 16 cents a shareEarnings Preview - TradingView
How CollPlant Biotechnologies Ltd. stock responds to policy changesLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
CollPlant Biotechnologies Ltd. stock retracement – recovery analysis2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
What technical patterns form on CollPlant Biotechnologies Ltd. (CPT) stock chartsJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Pattern recognition hints at CollPlant Biotechnologies Ltd. upsideMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Is CollPlant Biotechnologies Ltd. stock attractive after correctionMarket Activity Report & Daily Profit Focused Screening - newser.com
What momentum shifts mean for CollPlant Biotechnologies Ltd.2025 Biggest Moves & AI Driven Stock Reports - newser.com
What Analyst Ratings Reveal About Pacific Industries Limiteds Future ValueSector-Based Investing & Low Risk Capital Growth Plans - earlytimes.in
What drives CollPlant Biotechnologies Ltd CPT stock priceTop Performing Stocks & Backtest Your Strategy Before You Risk Money - earlytimes.in
CollPlant Biotechnologies Ltd. (CLGN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
EBITDA per share of CollPlant Biotechnologies Ltd – BER:CPT - TradingView
Applying sector rotation models to CollPlant Biotechnologies Ltd.2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Is CollPlant Biotechnologies Ltd. stock dividend yield sustainable2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Signal strength of CollPlant Biotechnologies Ltd. stock in tech scannersIndex Update & Weekly High Return Stock Forecasts - newser.com
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):